Risk Management Plans to Mitigate the Potential for Drug Shortages Guidance for Industry

Created by: Karen Ginsbury, MSc, BPharma,  CEO, PCI Pharmaceutical Consulting Israel Karen-Ginsbury_FDA-draft-guide-risk-mgmt-plans-drug-shortages-may-2022Download

To access this content, you must purchase MEMBER PLUS +.

You must log in to view this content.

Created by: Karen Ginsbury, MSc, BPharma,  CEO, PCI Pharmaceutical Consulting Israel Karen-Ginsbury_FDA-draft-guide-risk-mgmt-plans-drug-shortages-may-2022Download
To access this content, you must purchase MEMBER PLUS +.

Become a Member to View this Content

Please provide your information below